Member Info for WildStar

@ scardey_cat
Great link, thanks.

wrt:
"The manufacturer has been informed of the planned use of the tests for self-administered asymptomatic staff testing within the NHS."

Out of interest I would love to know if we have the manufacturer's response to that notification of change of use!

Mafeking relieved!
F me that GBnews never covers anything of interest!

OK, not a question...
FFS stop will you, you're only embarrassing yourself, but too dumb to realise.

You have zero, repeat ZERO credibility:
https://ibb.co/grzwnpw

'nuff said!

*disappointing

More Grrrrr

Just so dissapoining that all these 'pro' Innova pieces (in any guise) completely FAIL to mention that (even despite the suspicious data ) it was approved NASOPHARARYNGEAL ONLY! And NOT ANTERIOR NARES (AN) as is used by NHS and the UK population!!!

FFS when will this be common knowledge in the wider world!

Tweeted about this back in March and no-one is listening.

Grrrrr

Succinctly put EGTP :D

Only one reason.

"...then that could be the big announcement?"

Does there have to be a 'big announcement'?
It's just a business presentation. What, why, how we do stuff etc

They've also added:
" The test is intended for professional use only. "

...in the 'Inteded Use' section.

I've had Closing Only on IG SBs since at least last Tuesday.

*full of s h 1 t
(worth repeating anyway!)

I'm sure he meant the title to be, "Bighero is Kn*b of the week" but fell to the curse of the LSE spell corrector.
No-one can be that fully of s h 1 t surely!

@Lukeytukki
Some stuff to start your research:

With respect to the LFT...

------------------
Posted by Radiagreen - Today 11:58

Imagine this was available pre pandemic?

Critical that UK GOV secure for the future.
Features and Benefits
Patient-friendly – Anterior nares (nasal) swabs samples for more comfortable collection
Reliable Results – Accurate for identifying individuals likely to be infectious: 98% sensitivity and 99% specificity
Monitored Against Variants – Routine monitoring of emerging variants to ensure continued diagnostic accuracy
U.K. Made – Developed and manufactured in the United Kingdom
Accessible – Suitable for Point of Care settings and allows for decentralised testing
Rapid & Simple – Easy to use, simple work-flow, results in only 20 minutes
Convenient – Contains everything needed to run a test with no additional equipment required
Practical – Room temperature storage, transportation and testing

------------------

...and some info about other stuff going on

------------------
From Energyshares - 10 Jun 2021 08:41

I feel sorry for any genuine newbie shareholders that sold out listening to some of the garbage on here today.
Well as they said on Life of Brian :
Always look on the bright side of Life.

Oncology x 11
Ava6000,AVA7500,
AVA028,AVA7000,AVA004
AVA027,AVA3996 plus 4 undisclosed targets
Covid x 4
Affidx, Bams,Elisa,
Mologic combination test.
Plus in house pipe line non-COVID diagnostic tests, which include assays for D-dimer, cortisol, vitamins D and B12 and CRP.
LG Chem x 8
Every RNS states a multi-target deal with LG Chem worth up to $400m.
In the business update $98 million for the 2 below and up to $55m for each new product
So LG Chem has potentially 8 new products.
multi-target collaboration with LG Chem incorporating Avacta's Affimer XT™ serum half-life extension and LG Chem has Affimer PD-L1 inhibitortotalling $98million
The expanded partnership also provides LG Chem with rights to develop and commercialise other Affimer and non-Affimer biotherapeutics combined with Affimer XT half-life extension for a range of indications and Avacta could earn an additional $55m in milestone payments for each of these new products.
Daewoong x 2
Gene & stem cell with other targets
Point x 1
radiopharmaceutical prodrug
ADC x 3
three undisclosed cancer targets and provide these to ADC Therapeutics
Moderna x 1
exclusive license agreement with respect to certain Affimer molecules
Astrea x 1
Deepverge x 1
Biokit x 1
Abcam x 1

Presentation 21st news before then don’t let the trolls in your head.

------------------

I've probably missed some stuff but it's an immense amount to start your research on the amazing company and opportunity!
You have found it just in time!!

Good Luck
:D

"In fairness to the UK Gov, there was no British test to buy/use at the time they tendered Innova."

Great, that gives them the perfect 'easy' out to now do the right thing.

Brilliant point by Cellar Boy on twitter (sorry, can't remember your LSE username):

With respect to, will the UK follow suit?
"They are forced to. Just as an example with huge ramifications, if they want to open a US-UK air bridge with testing, which will be reliable LFTS, innova won't be accepted.

Would be a huge economic impact that won't be allowed. This is big news "

Absolutely!

https://twitter.com/boy_cellar/status/1403049985151848451

Surely this is the end for the Innova/Chinese test wrt to the UK as well!!

Amongst other major points by the FDA...
"FDA Actions - The FDA has classified the recall of this test as a Class I recall, the most serious type of recall. The FDA also has issued a warning letter to Innova Medical Group, Inc."

You're correct Malpenn, there was a thread around 13:00 yesterday discussing this.

You're correct Malpenn, there was a thread around 13:00 yesterday discussing this.

You're right gmcc...
As highlighted by Malpenn yesterday:
"Disclaimer: The AffiDX® SARS-Cov-2 rapid antigen test is not currently available for sale in the United States"

Can we read anything into the change to:
"Disclaimer: The AffiDX® SARS-CoV-2 rapid antigen test is currently registered for use in the UK market only." ?

There must be some wild ideas!
;)

...and now the hompage as well.

Product page just updated according to sitemap (https://avacta.com/page-sitemap.xml)

Can't see what's changed myself.
Any ideas?

https://avacta.com/diagnostics/products/